ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Exosomal miR-1275 Secreted by Prostate Cancer Cells Modulates Osteoblast Proliferation and Activity by Targeting the SIRT2/RUNX2 Cascade

Zou, Zihao*; Dai, Ranran; Deng, Nan; Su, Wei; Liu, Ping广州医学院; 南方医科大学
Cell Transplantation2021-10-21DOI: 10.1177/09636897211052977
6被引4阅读
引用收藏
分享

摘要

Prostate cancer (PCa) is one of the most frequently diagnosed malignancies and the second leading cause of cancer mortality among men worldwide. Modulation of osteoblast activity is involved in PCa metastasis, and miR-1275 is also reported to regulate PCa metastasis; however, the association between cancer-derived exosomal miR-1275 and osteoblast activity is unclear. Here, we isolated exosomes from PC3-derived conditioned medium by ultracentrifugation. We found that miR-1275 could be transferred from PCa cells to osteoblasts via exosomes. Exosomal miR-1275 significantly accelerated the proliferation of osteoblasts and the expression levels of osteoblast-specific genes, such as osteocalcin (OCN), type I collagen (COL-1), and osteopontin (OPN). Moreover, exosomal miR-1275 increased the expression of RUNX2, a master modulator of osteoblast activity, by down-regulation of SIRT2, which in turn influenced the growth and activity of osteoblasts. Our findings indicate that PCa-derived exosomal miR-1275 promotes the proliferation and activity of osteoblasts via modulation of SIRT2/Runx2 signaling.

学科与关键词

关键词
prostate cancerexosomesmiR-1275SIRT2osteoblast proliferation
相关
加载中…
  • Cancer-derived exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway
    Liu, Ying; Yang, Changmou; Chen, Shisheng; Liu, Weihao; Liang, Jingyi; He, Shuhua*; Hui, Jialiang*Cancer Gene Therapy, 2023, 30(3): 437-449.被引 5
  • Exosomes derived from PC-3 cells suppress osteoclast differentiation by downregulating miR-148a and blocking the PI3K/AKT/mTOR pathway
    Tian, Gaoqiang; Hu, Konghe; Qiu, Sujun; Xie, Yingming; Cao, Yanlin; Ni, Songjia*; Zhang, Lifang*Experimental and Therapeutic Medicine, 2021, 22(5): 1304.被引 2
  • MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis
    Gan, Junqing; Liu, Shan; Zhang, Yu; He, Liangzi; Bai, Lu; Liao, Ran; Zhao, Juan; Guo, Madi; Jiang, Wei; Li, Jiade; Li, Qi; Mu, Guannan; Wu, Yangjiazi; Wang, Xinling; Zhang, Xingli; Zhou, Dan; Lv, Huimin; Wang, Zhengfeng; Zhang, Yanqiao; Qian, Cheng; Feng, MeiYan; Chen, Hui; Meng, Qingwei; Huang, Xiaoyi*Experimental and Molecular Medicine, 2022, 54(8): 1290-1305.被引 16
查看全部 →

发表信息

论文状态
公开发表
期刊
Cell Transplantation
发表日期
2021-10-21
卷期
第 30 卷
页码
09636897211052977
DOI
10.1177/09636897211052977
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Guangdong Provincial Health Commission Project [A2009292]

作者

  • Z

    Zou, Zihao (通讯) (第一作者)

    guangzhou med univ

  • D

    Dai, Ranran

    guangzhou med univ

查看全部 5 位作者收起作者
  • D

    Deng, Nan

    guangzhou med univ

  • S

    Su, Wei

    southern med univ

  • L

    Liu, Ping

    guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417